Skin Cancer (Nonmelanoma)

New Treatments Aim to Increase Survival Rate
February 25, 2021

Cancer staging systems for squamous cell carcinoma have helped improve dermatologists’ ability to accurately stage the cancer, according to on expert.

Topical Actinic Keratosis Treatment Launched in US
February 23, 2021

Almirall announces the launch of tirbanibulin (Klisyri), a novel microtubule inhibitor for the topical treatment of actinic keratosis on the face or scalp.

Tirbanibulin Safe, Effective for AK on Face, Scalp
February 11, 2021

Topical microtubule inhibitor, tirbanibulin (Klisyri, Almirall), demonstrates positive results for treating actinic keratosis (AK) of the face and scalp, according recently published data from two phase 3 studies.